α-defensins 1, 2, and 3 are expressed by granulocytes in lymphoid tissues of HIV-1-seropositive and -seronegative individuals

Journal of Acquired Immune Deficiency Syndromes

Volumn 42, Issue 5, 2006, Pages 529-536

  Folkvord, Joy M ^a   McCarter, Martin D ^a   Ryder, John ^a   Meditz, Amie L ^a   Forster, Jeri E ^a   Connick, Elizabeth ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

defensins; CD15; HIV 1 infections; Innate immunity; Lymph nodes; Neutrophils

Indexed keywords

ALPHA DEFENSIN; ALPHA DEFENSIN 1; ALPHA DEFENSIN 2; ALPHA DEFENSIN 3; BIOLOGICAL MARKER; CD15 ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; GRANULOCYTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFECTION RISK; INGUINAL LYMPH NODE; LYMPH NODE CELL; LYMPHADENITIS; ORGAN WEIGHT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROLOGY; VIRUS REPLICATION;

ALPHA-DEFENSINS; ANTIGENS, CD15; FEMALE; GRANULOCYTES; HIV INFECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LYMPH NODES; LYMPHOID TISSUE; MALE; MICROSCOPY, FLUORESCENCE;

EID: 33746690399     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000225010.68815.1b     Document Type: Article

References (28)

1. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol. 2003;3(9):710-720.
2. Lehrer RI, Barton A, Daher KA, et al. Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J Clin Invest. 1989;84(2):553-561.
3. Lehrer RI, Ganz T, Szklarek D, et al. Modulation of the in vitro candidacidal activity of human neutrophil defensins by target cell metabolism and divalent cations. J Clin Invest. 1988;81(6):1829-1835.
4. Daher KA, Selsted ME, Lehrer RI. Direct inactivation of viruses by human granulocyte defensins. J Virol. 1986;60(3):1068-1074.
5. Zhang L, Yu W, He T, et al. Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science. 2002;298(5595):995-1000.
6. + T cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proc Natl Acad Sci U S A. 1995;92(6):2308-2312.
7. Zhang L, Lopez P, He T, et al. Retraction of an interpretation. Science. 2004;303(5657):467.
8. + T-cell supernatants are likely derived from residual granulocytes within the irradiated allogeneic peripheral blood mononuclear cells used as feeders. J Acquir Immune Defic Syndr. 2004;36(5):993-1005.
9. Mackewicz CE, Yuan J, Tran P, et al. alpha-Defensins can have anti-HIV activity but are not CD8 cell anti-HIV factors. AIDS. 2003;17(14):F23-F32.
10. Chang TL, Francois F, Mosoian A, et al. CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibition. J Virol. 2003;77(12):6777-6784.
11. Chang TL, Vargas J, DelPortillo A, et al. Dual role of alpha-defensin-1 in anti-HIV-1 innate immunity. J Clin Invest. 2005;115(3):765-773.
12. Agerberth B, Charo J, Werr J, et al. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood. 2000;96(9):3086-3093.
13. Trabattoni D, Caputo SL, Maffeis G, et al. Human alpha defensin in HIV-exposed but uninfected individuals. J Acquir Immune Defic Syndr. 2004;35(5):455-463.
14. Embretson J, Zupancic M, Ribas JL, et al. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature. 1993;362(6418):359-362.
15. Pantaleo G, Graziosi C, Demarest JF, et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature. 1993;362(6418):355-358.
16. + cells and HIV-1-producing cells in human lymphoid tissue in vivo. J Acquir Immune Defic Syndr. 2003;32(5):469-476.
17. Folkvord JM, Armon C, Connick E. Lymphoid follicles are sites of heightened human immunodeficiency virus type 1 (HIV-1) replication and reduced antiretroviral effector mechanisms. AIDS Res Hum Retroviruses. 2005;21(5):363-370.
18. Campbell TB, Schneider K, Wrin T, et al. Relationship between in vitro human immunodeficiency virus type 1 replication rate and virus load in plasma. J Virol. 2003;77(22):12105-12112.
19. Ihi T, Nakazato M, Mukae H, et al. Elevated concentrations of human neutrophil peptides in plasma, blood, and body fluids from patients with infections. Clin Infect Dis. 1997;25(5):1134-1140.
20. Kuhn L, Trabattoni D, Kankasa C, et al. alpha-Defensins in the prevention of HIV transmission among breastfed infants. J Acquir Immune Defic Syndr. 2005;39(2):138-142.
21. Chertov O, Michiel DF, Xu L, et al. Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J Biol Chem. 1996;271(6):2935-2940.
22. Obata-Onai A, Hashimoto S, Onai N, et al. Comprehensive gene expression analysis of human NK cells and CD8(+) T lymphocytes. Int Immunol. 2002;14(10):1085-1098.
23. + T cells. Science. 1995;270(5243):1811-1815.
24. Bleul CC, Farzan M, Choe H, et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature. 1996;382(6594):829- 833.
25. Wang W, Owen SM, Rudolph DL, et al. Activity of alpha- and theta-defensins against primary isolates of HIV-1. J Immunol. 2004;173(1):515-520.
26. Linzmeier R, Ho CH, Hoang BV, Ganz T. A 450-kb contig of defensin genes on human chromosome 8p23. Gene. 1999;233(1-2):205-211.
27. Tanaka S, Edberg JC, Chatham W, et al. Fc gamma RIIIb allele-sensitive release of alpha-defensins: anti-neutrophil cytoplasmic antibody-induced release of chemotaxins. J Immunol. 2003;171(11):6090-6096.
28. Anastassopoulou CG, Kostrikis LG. The impact of human allelic variation on HIV-1 disease. Curr HIV Res. 2003;1(2):185-203.